XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Drug Discovery World

JULY 3, 2023

DDW’s Diana Spencer speaks to the CEOs of two drug discovery start-ups to find out how they have overcome the challenges of launching a new company in a competitive market. It’s a challenging time to launch a new company in the life sciences sector. billion was raised by biopharma companies in 2022, down by 48.6%

Life Science 52

Life Science Pharma Companies Drugs Marketing 52

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. The development and widespread adoption of new technologies is key to revolutionizing the way we diagnose, prevent, treat and manage disease. They can be developed and adapted quickly.

Life Science 98

Life Science RNA Vaccination Vaccine 98

pharmaphorum

JANUARY 29, 2021

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. From CRM to CXM. About the interviewee. About Omnipresence.

Life Science 125

Life Science Sales Marketing Pharma Companies 125

pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 109

Pharma Companies Life Science Development Production 109

Drug Discovery World

DECEMBER 7, 2022

The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment. The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment.

Pharma Companies 52

Pharma Companies Life Science Regulation Scientist 52

pharmaphorum

MARCH 28, 2022

Noga Yerushalmi, investment director at M Ventures (the venture arm of Merck), tells us how AION Labs was formed and aspires to help ease the pharma industry’s shared challenges by offering its vast resources a new start-up. Then, a development stage or optimisation stage occurs. The partnership. ” The Application .

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

pharmaphorum

JANUARY 7, 2021

In an April survey conducted by Reuters and Omnipresence, 1,363 senior professionals mostly working in pharma (82.8%) in the EMEA region (73%) and biotech, medtech/device or consumer health companies reported on how life sciences organisations were adapting to the ‘new normal’. A unified approach. About Omnipresence.

Life Science 67

Life Science Sales Marketing Pharma Companies 67

pharmaphorum

APRIL 19, 2022

The first focuses on the patient journey through patient partnerships – spotting areas of challenge for specific patients and developing partnerships with different stakeholders outside Roche to improve upon the patient journey. The post The largest pharma company in Europe calls for interoperability appeared first on.

Pharma Companies 108

Pharma Companies Life Science Clinical Research Research 108

Drug Discovery World

OCTOBER 12, 2023

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform. However, in life science, labeled data are often in short supply. Traditional AI methods require vast amounts of labeled data to make accurate predictions.

Development 52

Development Protein Life Science Pharma Companies 52

XTalks

FEBRUARY 16, 2022

The drug was developed by Orchard Therapeutics and the NHS was able to negotiate a greater discount on it with the company so that it can offer it to patients in England. The team also talked about a digital risk report that revealed the existence of significant cybersecurity vulnerabilities among the world’s top pharma companies.

Life Science 52

Life Science Gene Therapy Drugs Pharma Companies 52

The Pharma Data

DECEMBER 9, 2020

This partnership provides SOLABS’ Life Sciences clients with exciting capabilities in the areas of reporting and analytics. MONTREAL, QC, December 09, 2020 /24-7PressRelease/ — SOLABS enters into a partnership with NexGen Analytics. NexGen has primarily focused on the Life Sciences industry.

Life Science 52

Life Science Packaging Packaging Pharma Companies 52

World of DTC Marketing

JANUARY 31, 2022

Fifteen percent of those surveyed said they trust pharma companies more than before. However, on the flip side, only 16% believe pharma companies “market their products in a trustworthy manner,” and just 17% would allow pharma companies to work with their doctors to manage a chronic illness.

Pharma Companies 218

Pharma Companies Life Science Vaccination Vaccine 218

STAT News

FEBRUARY 13, 2023

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche. and a leading researcher in cell biology.

Life Science 98

Life Science Pharma Companies Medicine Research 98

XTalks

MAY 20, 2021

In this episode, Ayesha discusses the latest trends in pharma tv ad spending, including the top spenders last week. The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall.

Life Science 52

Life Science Pharma Companies Development Drugs 52

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. About Fierce Innovation Awards.

Life Science 52

Life Science Clinical Research Coordinator Pharma Companies Clinical Research 52

XTalks

FEBRUARY 17, 2021

While an internal candidate search may seem easier at first glance, there are some inherent challenges associated with identifying and scoping out the relevant skills and expertise even within a company. This can be a particular problem in larger companies. The Importance of Both Expertise and Company Culture.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

XTalks

MARCH 30, 2022

Whether you are building a workable plan from scratch or simply improving it, the following methods can help develop your diversity and inclusion framework. Pharma companies must ensure that diversity and inclusion programs are taken seriously and turn them into long term components of their diversity and inclusion framework plan.

Pharma Companies 59

Pharma Companies Life Science Engineer Development 59

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. According to McKinsey & Company: “Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing… .

Development 52

Development Drugs Life Science Marketing 52

XTalks

OCTOBER 4, 2023

How do you make strategic decisions around products that are in the early stage of development and are still years from regulatory approval and launch? In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

JUNE 6, 2022

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. pic.twitter.com/MUKcXaganu. — Limitless Minds (@Thinkbig_gofar) July 25, 2019.

Sales 111

Sales Life Science Pharma Companies Marketing 111

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. This article takes a closer look at several key clusters in the region.

Drugs 59

Drugs Life Science Gene Editing Gene 59

Drug Discovery World

FEBRUARY 10, 2023

Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

Pharmaceutical Technology

JULY 26, 2022

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. In January last year, NewAmsterdam Pharma raised $196m in a Series A funding round to support the full Phase III development of obicetrapib.

Life Science 147

Life Science Trials Pharma Companies Production 147

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

pharmaphorum

NOVEMBER 8, 2022

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the affirmative. Suchotliff sat down with Deep Dive to discuss the current state of patient centricity in pharma, some of the common foibles and misconceptions, and how pharma companies can get themselves on the right track. “I

Life Science 52

Life Science Pharma Companies Branding Development 52

Drug Discovery World

MAY 29, 2024

SpyBiotech and the University of Oxford Biotechnology company SpyBiotech and University of Oxford have entered a research agreement for the development of a vaccine against Epstein-Barr virus (EBV). We see a great need for a vaccine against EBV.” Sartorius has been working with NVIDIA since 2020. GSK’s £45 ($57.5)

Drugs 52

Drugs Gene Editing Life Science Genome 52

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 109

Life Science Engineer Scientist Pharma Companies 109

Drug Discovery World

OCTOBER 18, 2022

The second phase will see it develop a methodology for calculating the carbon footprint of both trial models. The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

Drug Discovery World

OCTOBER 16, 2023

Cambridge boasts the world-renowned university alongside a biotech and pharma cluster situated throughout the city and its surrounding science parks, all of which helps attract top scientific talent.” The university aims to identify treatments for life-threatening anti-microbial diseases and metabolic disorders.

Drugs 75

Drugs Life Science Gene Therapy Genome 75